Hair Growth Supplement and Treatment Market – By Type (Supplements {Powder, Gummies, Tablets, Capsules}, Pharmaceuticals {Oral, Devices}, By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, E-commerce) – Global Forecast (2024 ­ 2032)

Hair Growth Supplement and Treatment Market – By Type (Supplements {Powder, Gummies, Tablets, Capsules}, Pharmaceuticals {Oral, Devices}, By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, E-commerce) – Global Forecast (2024 ­ 2032)

Hair Growth Supplement and Treatment Market Size

Hair Growth Supplement and Treatment Market size was valued at USD 7.8 billion in 2023 growing at a CAGR of 6.1% from 2024 and 2032, driven by factors such as the increasing prevalence of hair disorders such as alopecia areata, telogen effluvium, and other scalp conditions that has heightened the need for effective treatments as people seek to improve their appearance and confidence.

To get key market trends

  Download Free Sample

For instance, as per the report published by National Alopecia Areata Foundation, alopecia areata affects about 160 million people worldwide and nearly 6.7 million people in the U.S. alone. Although alopecia areata can begin at any age, most individuals develop the disease early in life. More than 80% show signs of the disease before age 40, and 40% experience symptoms by age 20. Thus, the rapid increase in the prevalence of hair disorder globally is the major factor that is anticipated to increase the demand for hair growth supplements and pharmaceutical dosage forms, thereby boosting the market growth.

What are the growth opportunities in this market?

 Download Free Sample

Hair growth supplement contain ingredients that are believed to help the hair grow, such as specific or a variety of nutrients and/or botanicals. Hair supplements may help to support hair growth and hair health in people who have a deficiency or suboptimal levels of certain nutrients. In addition, the hair loss treatments are meant to help with androgenic alopecia in male and female pattern hair loss. These treatments include medications and device including laser caps.

Hair Growth Supplement and Treatment Market Trends

The increasing prevalence of hair disorders significantly drives the market.

• For instance, as per an article published by UnitedCare in May 2024, it has been reported that an average person a day loses about 100 hair stands per day. In current statistics, by the age of 30, 25% men and 12% women lose hair. In addition, 95% of hair loss in men is caused by androgenetic alopecia or common male pattern baldness. Thus, with the rise in the adoption of unhealthy diets, stress and pollution hair loss become more and more common. Therefore, the high prevalence of hair loss necessitates an increasing product demand, thereby driving market growth.
• Moreover, there is a rising trend towards natural and organic hair care products. Nowadays, consumers are increasingly looking for supplements and treatments that contain natural ingredients and are free from harmful chemicals. This demand stimulates research and development in hair supplements manufacturing, leading to the introduction of advanced therapies that further drive market growth.

Hair Growth Supplement and Treatment Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on the type, the global market is classified into supplements and pharmaceuticals. The pharmaceuticals segment dominated the market with revenue of USD 5.6 billion in 2023.

• The increasing incidence of hair loss conditions such as androgenetic alopecia and alopecia areata is driving demand for pharmaceutical treatments. These conditions are often medically diagnosed, leading patients to seek prescription treatments from dermatologists and healthcare providers.
• Moreover, ongoing research and development in the field of hair growth has enabled pharmaceuticals to the introduce new and improved treatments. Innovations such as novel drug delivery systems, combination therapies, and new active ingredients enhance treatment efficacy and patient compliance. Thus, aforementioned factor is expected to spur the segmental growth.

Learn more about the key segments shaping this market

 Download Free Sample

Based on the gender, the global hair growth supplement and treatment market is classified into male and female. The male segment dominated with market share of 61.1% in 2023 and is expected to dominate throughout the analysis period.

• Hair loss is a common issue among men, with conditions like male pattern baldness affecting a significant portion of the male population. As the incidence of hair loss rises, so does the demand for effective treatments and supplements. Also, there is a growing emphasis on personal grooming and aesthetics among men. The desire to maintain a youthful appearance and boost self-confidence contributes to the demand for hair growth solutions.
• Thus, the rise in technological advancements and innovations in the hair growth industry including improved formulations and more effective ingredients have made treatments more accessible and attractive to men. Such advantages associated with products will augment the market growth.

Based on distribution channel, the hair growth supplement and treatment market are classified into hospital pharmacies, e-commerce, retail pharmacies, and other distribution channels. The hospital pharmacies segment is expected to exhibit 6.4% CAGR between 2024 - 2032.

• There is an increasing awareness among the population about hair loss conditions and the availability of effective treatments. Therefore, improved diagnostic techniques in hospitals will contribute to the identification and treatment of hair-related issues.
• Moreover, hospital pharmacies are often viewed as more reliable sources for medical treatments. Patients trust hospital-based pharmacists and healthcare professionals for their expertise and recommendations, leading to a preference for obtaining hair growth treatments from these settings.
• Furthermore, many effective hair growth treatments are available only through prescriptions. Therefore, hospital pharmacies, being a primary source of prescription medications, see increased demand for these treatments.

Looking for region specific data?

 Download Free Sample

In 2023, North America secured a substantial market share of 44.5% in the global hair growth supplement and treatment market and is expected to dominate throughout the forecast period.

• North America has a significant prevalence of hair loss issues, such as androgenetic alopecia. This widespread occurrence is a primary driver for the demand for hair growth products. Also, the presence of many leading companies in the hair care industry in North America is another influencing factor for regional market growth.
• The companies invest heavily in research and development and distribution which support to cater to large consumer base that are increasingly aware of the importance of maintaining healthy hair. Thus, the aforementioned factor contributed to North America's dominance in the market.

UK to experience the highest growth rate in the market, outstripping other countries in Europe in the assessment period.

• Hair disorders, such as androgenetic alopecia, are relatively common in the UK. The increasing incidence of these conditions is boosting the demand for effective androgenetic alopecia treatment.
• For instance, as per the report published by The Treatment Rooms London, in January 2024, approximately 6.5 million men and 8 million women in the UK are currently affected by hair loss. The most common cause of hair loss is androgenic alopecia or male/ female pattern hair loss which affects 85% of men by the age of 50 and 40% of women by the age of 50.
• Thus, the easy availability and accessibility of hair growth products in both physical and online stores have made it easier for UK consumers to access these products, thereby enhancing market growth.

The India hair growth supplement and treatment market is expected to grow with a significant CAGR during the forecast period.

• Urbanization and the associated lifestyle changes including increased stress, pollution, and dietary habits have led to a rise in hair-related issues in India. This has boosted the demand for hair growth products among the urban population that is anticipated to propel the growth of the market.
• Moreover, there is a strong preference for natural and ayurvedic products in India. Consumers tend to trust and favor hair growth supplements and treatments that are based on traditional ayurvedic ingredients and natural formulations. Such aforementioned factors will foster the country level market growth.

Hair Growth Supplement and Treatment Market Share

The competitive landscape of the market is characterized by the presence of both established nutraceutical and pharmaceutical companies that manufacture advanced hair growth supplement and pharmaceutical treatment products vying for market share. Key players are engaging in strategic initiatives such as collaboration, product launch, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for hair growth supplement and treatment.

Hair Growth Supplement and Treatment Market Companies

Prominent players operating in the market are as mentioned below

• Hair supplements
  • Amway Corporation
  • GNC Holdings, Inc.
  • HUM Nutrition
  • Nature’s Bounty
  • Nutraceutical Wellness, Inc.
  • OUAI Healthcare
  • Phyto
  • Viviscal Limited (Church & Dwight Co., Inc.)
• Hair treatment
  • Cipla Limited
  • Curallux, LLC
  • Eli Lilly, and Company
  • ExoCoBio, Inc
  • Keranique
  • Lexington International
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Rogaine (Johnson & Johnson)

Hair Growth Supplement and Treatment Industry News

• In June 2023, Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LITFULO (ritlecitinib), a once-daily oral treatment, for individuals 12 years of age and older with severe alopecia areata. The approved recommended dose for LITFULO is 50 mg. This strategy enabled company to expand its product offerings and generate revenue from its sales.
• In June 2022, Eli Lilly, and Company and Incyte announced that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT (baricitinib), a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia areata (AA), available as 4-mg, 2-mg, and 1-mg tablets. This strategy helped company to add value to its existing business portfolio.

The hair growth supplement and treatment market research report include an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Type

• Supplements
  • Powder
  • Gummies
  • Tablets
  • Capsules
  • Liquid
  • Other dosage forms
• Pharmaceuticals
  • Oral
  • Topical & injectables
  • Devices

Market, By Gender

• Male
• Female

 Market, By Distribution Channel

• Hospital pharmacies
• E-commerce
• Retail pharmacies
• Other distribution channels

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudia Arabia
  • UAE
  • Rest of Middle East and Africa